Day One Biopharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DAWN Nasdaq 8731 https://dayonebio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Day One Biopharmaceuticals Inc

Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) - Sep 12th, 2023 1:02 am
Jeff Bezos Used These Strategies for Business Success: Here’s Why They Work - Aug 18th, 2023 12:00 pm
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience - Aug 16th, 2023 12:00 pm
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress - Aug 7th, 2023 8:30 pm
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) is favoured by institutional owners who hold 54% of the company - Jun 17th, 2023 12:29 pm
Day One Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares - Jun 12th, 2023 12:00 pm
Biotech Stock Roundup: GSK Provides Updates, Biogen to Discontinue Study & More - Jun 8th, 2023 4:38 pm
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA - Jun 8th, 2023 11:00 am
Day One Announces Pricing of Public Offering of Common Stock - Jun 7th, 2023 2:31 am
Day One Announces Proposed Public Offering of Common Stock - Jun 6th, 2023 8:01 pm
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips - Jun 5th, 2023 8:06 pm
Why Shares of Day One Pharmaceuticals Are Up Monday - Jun 5th, 2023 4:30 pm
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma - Jun 4th, 2023 4:45 pm
Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference - May 30th, 2023 12:00 pm
CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - May 26th, 2023 12:30 am
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - May 25th, 2023 9:00 pm
Day One Reports First Quarter 2023 Financial Results and Corporate Progress - May 1st, 2023 1:00 pm
We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth - Apr 30th, 2023 1:57 pm
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - Apr 26th, 2023 1:31 pm
Leaked: Apple's Secret Health Play Could Push Out Smaller Apps - Apr 21st, 2023 5:02 pm